ES2377796B8 - Procedimiento para preparar productos de terapia celular o ingeniería tisular. - Google Patents

Procedimiento para preparar productos de terapia celular o ingeniería tisular. Download PDF

Info

Publication number
ES2377796B8
ES2377796B8 ES201131906A ES201131906A ES2377796B8 ES 2377796 B8 ES2377796 B8 ES 2377796B8 ES 201131906 A ES201131906 A ES 201131906A ES 201131906 A ES201131906 A ES 201131906A ES 2377796 B8 ES2377796 B8 ES 2377796B8
Authority
ES
Spain
Prior art keywords
procedure
engineering
tissular
cellular therapy
prepare products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201131906A
Other languages
English (en)
Other versions
ES2377796A1 (es
ES2377796B1 (es
Inventor
Pablo Arnau Pla Calvet
Andrés RAYA DONET
Juan García López
Irene Oliver Vila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Banc de Sang i Teixits
Original Assignee
Banc de Sang i Teixits
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banc de Sang i Teixits filed Critical Banc de Sang i Teixits
Priority to ES201131906A priority Critical patent/ES2377796B8/es
Publication of ES2377796A1 publication Critical patent/ES2377796A1/es
Publication of ES2377796B1 publication Critical patent/ES2377796B1/es
Priority to PCT/ES2012/070792 priority patent/WO2013076330A1/es
Application granted granted Critical
Publication of ES2377796B8 publication Critical patent/ES2377796B8/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Procedimiento para preparar productos de terapia celular o ingeniería tisular. Procedimiento de preparación de un producto para terapia celular o ingeniería tisular que comprende las etapas de: a) obtener material celular de un paciente; b) seleccionar la población o poblaciones celulares de interés; c) determinar parámetros de calidad de la población celular seleccionada; d) combinar el material celular obtenido en la etapa (c) con un producto bioactivo; y e) determinar parámetros de calidad del producto obtenido en la etapa (d).
ES201131906A 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular. Expired - Fee Related ES2377796B8 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201131906A ES2377796B8 (es) 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular.
PCT/ES2012/070792 WO2013076330A1 (es) 2011-11-25 2012-11-14 Procedimiento para preparar productos de terapia celular o ingeniería tisular

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201131906A ES2377796B8 (es) 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular.

Publications (3)

Publication Number Publication Date
ES2377796A1 ES2377796A1 (es) 2012-04-02
ES2377796B1 ES2377796B1 (es) 2012-08-13
ES2377796B8 true ES2377796B8 (es) 2012-12-28

Family

ID=45840670

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201131906A Expired - Fee Related ES2377796B8 (es) 2011-11-25 2011-11-25 Procedimiento para preparar productos de terapia celular o ingeniería tisular.

Country Status (2)

Country Link
ES (1) ES2377796B8 (es)
WO (1) WO2013076330A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1588099A (en) * 1997-11-17 1999-06-07 Beth Israel Deaconess Medical Center Hybrid tissues for tissue engineering
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
ES2334298B1 (es) * 2007-10-15 2011-01-24 Consejo Superior De Investigaciones Cientificas Constructo util para terapia de regeneracion de tejidos, procedimiento de obtencion y aplicaciones.
US20120020925A1 (en) * 2009-02-04 2012-01-26 Grove Robert I Therapeutic Use of Specialized Endothelial Progenitor Cells
ES2471367T3 (es) * 2010-07-30 2014-06-26 Institut Quimic De Sarria Implante bioactivo
ES2362021B1 (es) * 2011-05-27 2011-11-24 Banc De Sang I Teixits Procedimiento para la obtención de un producto de ingeniería tisular orientado a la regeneración de tejido cartilaginoso.

Also Published As

Publication number Publication date
ES2377796A1 (es) 2012-04-02
WO2013076330A1 (es) 2013-05-30
ES2377796B1 (es) 2012-08-13

Similar Documents

Publication Publication Date Title
BR112014005752A2 (pt) plataforma para tecidos e órgãos implantáveis produzidos por engenharia tecidual e métodos para sua produção
EP2785360A4 (en) PLASMA TREATMENT PLANTS MADE BY CHEMICAL DEHYDRATION / FREEZING, AND METHOD FOR THE PRODUCTION AND USE THEREOF
AR101158A1 (es) Recipiente y método para preparar productos helados o congelados
CO6862129A2 (es) Aparato y proceso para la producción de un producto de células encapsuladas
BR112016019677A2 (pt) método de preparação de um condensado celular in vitro, condensado celular, método de preparação de uma estrutura tissular tridimensional e suporte de cultura semelhante a gel
BR112015018306A2 (pt) tambor e aparelho de formação de alimento, membro poroso, unidade móvel para transportar o tambor, método para trocar um tambor, e métodos para limpar, operar e produzir um aparelho
CL2013001770A1 (es) Proceso para la fabricacion de productos autoclavado de fibrocemento; y producto autoclavado de fibrocemento.
BR112014003137A2 (pt) processo para recuperação de um material contendo proteína, processo para preparar uma composição de ração animal, composição de ração animal, aparelho para produzir etanol e um agente de fermentação contendo proteína, material contendo proteína, processo para recuperação de um material contendo proteína e aparelho para produzir etanol
CL2016001510A1 (es) Células madre derivadas de musculo de mamifero
PL2911524T3 (pl) Sposób wytwarzania kompozycji białkowych o słabej rozpuszczalności, otrzymane kompozycje i ich zastosowanie w produktach wypieku pieczywa
EP3395943A4 (en) PROCESS FOR PRODUCING TISSUE / ORGANS BY MEANS OF BLOOD CELLS
IL274873A (en) A method for creating a cell mass including pituitary gland tissue, and its cell mass
ZA201705173B (en) In vitro method for estimating in vivo protein digestibility
WO2014022701A3 (en) An improved continuous process and apparatus for making a pita chip
AR088166A1 (es) Metodo para la preservacion de tejido vivo
BR112014015232A2 (pt) procedimento para preparar produto alimentício, e, produto alimentício
EP2719704A4 (en) PROCESS FOR PRODUCING INJECTABLE FORMULATIONS FROM BLOOD-DERIVED PROTEIN MATERIAL AND MATERIALS PRODUCED BY THIS METHOD
AP2013007066A0 (en) Polyester-based fiber for artificial hair and ornament product including the same, and method for producing the same
EP3279311A4 (en) Artificial skin culture container and method for producing artificial skin using same
ES2377796B8 (es) Procedimiento para preparar productos de terapia celular o ingeniería tisular.
FR2981851B1 (fr) Produit composite, notamment implant medical par exemple bille intraoculaire, et procede de fabrication
PH12016501630B1 (en) Method for producing a fibrous cheese product
FR2950074B1 (fr) Equivalent de peau in vitro et procede de preparation
HK1206207A1 (en) Methods for producing roux and starting material thereof, roux, cream source and frozen food
MX2016014628A (es) Metodo para expandir las celulas madre adultas de sangre entera.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2377796

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20120813

FD2A Announcement of lapse in spain

Effective date: 20210915